242 related articles for article (PubMed ID: 18477255)
1. Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy.
Wolff CS; Castillo SF; Larson DR; O'Byrne MM; Fredericksen M; Deschamps C; Allen MS; Zais TG; Romero Y
Dis Esophagus; 2008; 21(4):328-33. PubMed ID: 18477255
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial.
Li B; Xiang J; Zhang Y; Li H; Zhang J; Sun Y; Hu H; Miao L; Ma L; Luo X; Chen S; Ye T; Zhang Y; Zhang Y; Chen H
JAMA Surg; 2015 Apr; 150(4):292-8. PubMed ID: 25650816
[TBL] [Abstract][Full Text] [Related]
3. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
4. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis on the classic and modified Ivor-Lewis procedure in the treatment of mid-low thoracic esophageal carcinoma].
Zhen FX; Luo JH; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Dec; 16(12):1180-2. PubMed ID: 24369401
[TBL] [Abstract][Full Text] [Related]
7. [Short-term clinical efficacies of esophageal carcinoma treated surgically by Ivor-Lewis approach].
Ma LF; Xiang JQ; Li HC; Li B; Hu H
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1618-20. PubMed ID: 22944131
[TBL] [Abstract][Full Text] [Related]
8. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
Salem AI; Thau MR; Strom TJ; Abbott AM; Saeed N; Almhanna K; Hoffe SE; Shridhar R; Karl RC; Meredith KL
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27149640
[TBL] [Abstract][Full Text] [Related]
9. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
10. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
11. Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer.
Stilidi I; Davydov M; Bokhyan V; Suleymanov E
Eur J Cardiothorac Surg; 2003 Mar; 23(3):415-20. PubMed ID: 12614816
[TBL] [Abstract][Full Text] [Related]
12. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
Chen G; Wang Z; Liu XY; Liu FY
World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
[TBL] [Abstract][Full Text] [Related]
13. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
Shim YM; Park JS; Lee M; Kim D; Kim K
Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
[TBL] [Abstract][Full Text] [Related]
14. A preliminary experience with minimally invasive Ivor Lewis esophagectomy.
Tapias LF; Morse CR
Dis Esophagus; 2012 Jul; 25(5):449-55. PubMed ID: 21967644
[TBL] [Abstract][Full Text] [Related]
15. The sweet approach is still worthwhile in modern esophagectomy.
Ma J; Zhan C; Wang L; Jiang W; Zhang Y; Shi Y; Wang Q
Ann Thorac Surg; 2014 May; 97(5):1728-33. PubMed ID: 24650587
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
17. Initial experience of total thoracoscopic and laparoscopic Ivor Lewis esophagectomy.
Merritt RE
J Laparoendosc Adv Surg Tech A; 2012 Apr; 22(3):214-9. PubMed ID: 22393924
[TBL] [Abstract][Full Text] [Related]
18. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
Schomas DA; Quevedo JF; Donahue JM; Nichols FC; Romero Y; Miller RC
Dis Esophagus; 2010 Apr; 23(3):232-9. PubMed ID: 19515184
[TBL] [Abstract][Full Text] [Related]
19. BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.
Tian Y; Wang C; Lu M
Surg Today; 2019 Feb; 49(2):158-169. PubMed ID: 30182305
[TBL] [Abstract][Full Text] [Related]
20. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
